MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
-$4,714K
Free Cash flow
-$27,278K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Maturities of marketable securit...
Stock-based compensation expense
Accrued expenses and other curre...
Others
Negative Cash Flow Breakdown
Net loss
Accretion on marketable securiti...
Operating lease assets and liabi...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
-44,079
-183,440
-29,092
-30,612
Depreciation and amortization
716
723
743
755
Stock-based compensation expense
9,606
8,460
5,823
5,965
In-process research and development expenses
0
150,000
0
2,000
Accretion on marketable securities, net
528
746
580
1,022
Realized gain from sales of marketable securities, net
0
47
-
-
Prepaid expenses and other current and long-term assets
-1,000
-175
-2,176
903
Accounts payable
-212
1,182
-2,048
1,366
Accrued expenses and other current and long-term liabilities
6,677
-3,269
1,670
1,190
Operating lease assets and liabilities, net
450
421
403
397
Net cash used in operating activities
-27,270
-27,383
-21,711
-21,658
Purchases of marketable securities
0
253,170
42,230
41,540
Maturities of marketable securities
19,500
58,550
66,950
71,250
Sales of marketable securities
0
100,826
-
-
In-process research and development
0
150,000
0
4,000
Purchases of property and equipment
8
36
9
6
Net cash (used in) provided by investing activities
19,492
-243,830
24,711
25,704
Proceeds from issuance of common stock in underwritten offering
0
258,750
-
-
Issuance costs associated with underwritten offering
0
16,044
-
-
Payments of deferred offering costs
300
-
-
-
Proceeds from the exercise of stock options
2,595
1,958
255
41
Proceeds from issuance of common stock under the employee stock purchase plan
769
-
320
0
Net cash provided by financing activities
3,064
244,664
575
41
Net decrease in cash, cash equivalents, and restricted cash
-4,714
-26,549
3,575
4,087
Cash, cash equivalents and restricted cash at beginning of the period
47,664
74,213
70,638
68,147
Cash, cash equivalents and restricted cash at end of the period
42,950
47,664
74,213
70,638
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Maturities of marketable
securities
$19,500K
(-84.12%↓ Y/Y)
Proceeds from the
exercise of stock options
$2,595K
(3314.47%↑ Y/Y)
Proceeds from issuance of
common stock under the...
$769K
(90.35%↑ Y/Y)
Net cash (used in)
provided by investing...
$19,492K
(-61.02%↓ Y/Y)
Net cash provided by
financing activities
$3,064K
(538.33%↑ Y/Y)
Canceled cashflow
$8K
Canceled cashflow
$300K
Net decrease in
cash, cash...
-$4,714K
(-195.36%↓ Y/Y)
Canceled cashflow
$22,556K
Stock-based compensation
expense
$9,606K
(-26.73%↓ Y/Y)
Accrued expenses and
other current and...
$6,677K
(200.74%↑ Y/Y)
Prepaid expenses and
other current and...
-$1,000K
(-93.80%↓ Y/Y)
Depreciation and
amortization
$716K
(-55.50%↓ Y/Y)
Purchases of property and
equipment
$8K
(-92.92%↓ Y/Y)
Payments of deferred
offering costs
$300K
Net cash used in
operating activities
-$27,270K
(47.64%↑ Y/Y)
Canceled cashflow
$17,999K
Net loss
-$44,079K
(32.02%↑ Y/Y)
Accretion on marketable
securities, net
$528K
(-84.85%↓ Y/Y)
Operating lease assets and
liabilities, net
$450K
(-57.63%↓ Y/Y)
Accounts payable
-$212K
(-117.74%↓ Y/Y)
Buy us a coffee
Erasca, Inc. (ERAS)
Erasca, Inc. (ERAS)